Jonathan Solomon
Vorstandsvorsitzender bei BIOMX INC.
Vermögen: 8 400 $ am 30.04.2024
Aktive Positionen von Jonathan Solomon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOMX INC. | Direktor/Vorstandsmitglied | 28.10.2019 | - |
Vorstandsvorsitzender | 28.10.2019 | - | |
Solomon Holdings Ltd.
Solomon Holdings Ltd. Real Estate DevelopmentFinance Solomon Holdings Ltd. engages in the provision of real estate services. It also initiates and executes residential construction projects, and invests in income-generating real estate properties. The company was founded on July 6, 1989 and is headquartered in Herzliya, Israel. | Direktor/Vorstandsmitglied | 07.03.2013 | - |
Vorsitzender | 06.07.2010 | 07.03.2013 | |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Direktor/Vorstandsmitglied | 01.05.2017 | - |
Vorstandsvorsitzender | 01.05.2017 | - |
Karriereverlauf von Jonathan Solomon
Ehemalige bekannte Positionen von Jonathan Solomon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 01.07.2006 | 05.03.2014 |
Vorstandsvorsitzender | 01.07.2006 | 01.12.2015 | |
Gründer | 01.07.2006 | 01.12.2015 | |
Public Communications Contact | 01.07.2006 | 01.12.2015 | |
Präsident | 01.07.2006 | 04.11.2014 | |
Medtronic Corp. | Corporate Officer/Principal | - | - |
Ausbildung von Jonathan Solomon
Tel-Aviv University | Graduate Degree |
The Hebrew University of Jerusalem | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Statistik
International
Israel | 6 |
Vereinigte Staaten | 4 |
Operativ
Director/Board Member | 4 |
Chief Executive Officer | 3 |
Chairman | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 4 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOMX INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Solomon Holdings Ltd.
Solomon Holdings Ltd. Real Estate DevelopmentFinance Solomon Holdings Ltd. engages in the provision of real estate services. It also initiates and executes residential construction projects, and invests in income-generating real estate properties. The company was founded on July 6, 1989 and is headquartered in Herzliya, Israel. | Finance |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Health Technology |
Medtronic Corp. | |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
- Börse
- Insiders
- Jonathan Solomon
- Erfahrung